Browsing by Keyword : Angiogenesis Inhibitors
Showing results 5 to 16 of 16
Pub Year | | Title | AJOU Author(s) |
2020 | | Effect of a Single Intravitreal Bevacizumab Injection on Proteinuria in Patients With Diabetes | 김영호, 변혜은, 이기황, 정유리 |
2012 | | Effect of intravitreal bevacizumab (Avastin(®)) therapy in malignant hypertensive retinopathy: a report of two cases | 송지훈, 유호민 |
2023 | | Efficacy of as-needed intravitreal injection compared to 3-monthly loading of anti-vascular endothelial growth factor agents for branch retinal vein occlusion | 이기황, 정유리 |
2016 | | Hypertension as a risk factor for recurrent subretinal hemorrhage in polypoidal choroidal vasculopathy | 양홍석, 이기황, 정유리 |
2020 | | Inhibition of Hypoxia-Inducible Factor-1alpha and Vascular Endothelial Growth Factor by Chrysin in a Rat Model of Choroidal Neovascularization | 송지훈 |
2010 | | Intravitreal bevacizumab in the management of subretinal fluid associated with choroidal osteoma. | 송지훈 |
2021 | | Real-world incidence of endopthalmitis after intravitreal anti-VEGF injections in Korea: Findings from the Common Data Model in ophthalmology | 박래웅, 송지훈, 이기황, 정유리 |
2022 | | Real-world treatment intensities and pathways of macular edema following retinal vein occlusion in Korea from Common Data Model in ophthalmology | 박래웅, 송지훈, 이기황, 정유리 |
2015 | | Reply to 'Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review'. | 이기황, 정유리 |
2018 | | Subfoveal Choroidal Thickness and Vascular Diameter in Active and Resolved Central Serous Chorioretinopathy | 이기황, 정유리 |
2021 | | Transient accumulation of subretinal fluid after half-fluence photodynamic therapy in neovascular age-related macular degeneration | 송지훈, 정유리 |
2019 | | Twelve-Month Efficacy of Intravitreal Bevacizumab Injection for Chronic, Atypical, or Recurrent Central Serous Chorioretinopathy | 송지훈, 정유리 |
1